Mazdutide Import Supplier — Australia

Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.

Aarise Healthcare exports Mazdutide (CAS: 2270319-02-5) to research institutions in Australia. Our WHO-GMP certified facility in India supplies 98%+ purity Mazdutide for GLP-1/glucagon dual receptor research.

Mazdutide Export Specifications for Australia

Compound	Mazdutide
CAS Number	2270319-02-5
Purity	98%+ (HPLC verified)
Form	Lyophilised powder
Regulatory Reference	TGA
Shipping	DHL/FedEx temperature-controlled
Transit to Australia	5-10 business days
Documentation	CoA, HPLC, MS, export docs

Research Applications of Mazdutide

Mazdutide is used in GLP-1/glucagon dual receptor research. Research institutions in Australia source this compound for preclinical studies under applicable TGA research regulations.

Why Australia Researchers Source Mazdutide from India

• WHO-GMP certified Indian manufacturer — internationally recognised compliance
• Competitive pricing for bulk research quantities
• Full export documentation package for TGA compliance
• Temperature-controlled DHL/FedEx shipping to Australia
• Dedicated international research supply team
• 98%+ purity guaranteed with independent third-party CoA

Related Peptides in Australia

Semaglutide in Australia | Tirzepatide in Australia | Retatrutide in Australia | Liraglutide in Australia

Mazdutide — Other Countries

Mazdutide in USA | Mazdutide in UK | Mazdutide in Germany | Mazdutide in Canada

Source from India — Key Manufacturing Cities

Mazdutide in Mumbai, India | Mazdutide in Delhi, India | Mazdutide in Hyderabad, India | Mazdutide in Bangalore, India

Request Mazdutide for your Australia research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.